ModelEdge
MDxHealth
MDXH
Filing type
20-F
Filing date
Apr 2, 2026
Updated
Apr 2, 2026 ยท 3:40 PM

Filing

20-FAnnual and Transition Report of Foreign Private Issuers

Exhibits

EX-1.1ARTICLES OF ASSOCIATION OF MDXHEALTH SA (ENGLISH TRANSLATION)EX-1.2CORPORATE GOVERNANCE CHARTER OF MDXHEALTH SA (ENGLISH TRANSLATION)EX-2.1DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACTEX-4.33THIRD AMENDMENT TO CREDIT AGREEMENT, DATED AUGUST 5, 2025, BY AND AMONG THE COMPANY, AS GUARANTOR, MDXHEALTH, INC., AS BORROWER, AND ONE OR MORE AFFILIATES OF ORBIMED, AS THE LENDERS AND ADMINISTRATIVE AGENT #EX-4.35THIRD AMENDMENT TO ASSET PURCHASE AGREEMENT BETWEEN GENOMIC HEALTH, INC. AND MDXHEALTH SA DATED AUGUST 23, 2023EX-4.36FOURTH AMENDMENT TO ASSET PURCHASE AGREEMENT BETWEEN GENOMIC HEALTH, INC. AND MDXHEALTH SA DATED JANUARY 9, 2026EX-4.37EQUITY PURCHASE AGREEMENT BY AND AMONG MDXHEALTH SA, EXOSOME DIAGNOSTICS, INC. AND BIO-TECHNE CORPORATION, DATED AUGUST 5, 2025EX-4.38SUBLEASE AGREEMENT EXOSOME DIAGNOSTICS, INC. AND BIO-TECHNE CORPORATION, DATED SEPTEMBER 15, 2025EX-12.1CERTIFICATIONEX-12.2CERTIFICATIONEX-13.1CERTIFICATIONEX-13.2CERTIFICATIONEX-15.1CONSENT OF BDO REVISEURS D' ENTREPRISES SRL, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphic